House Republicans rip prospect of Medicare drug price negotiations

The drug price policies of the federal Inflation Reduction Act were the subject of a Sept. 20 hearing of the Oversight and Investigations Subcommittee of the U.S. House of Representatives' Energy& Commerce Committee. The U.S. Centers for Medicare& Medicaid Services is staging "so-called negotiation… not a true negotiation," said subcommittee Chair Rep.